Clinical development costs are rising due to the disruption of shipping routes in the Strait of Hormuz, writes Mathini ...

Novo Nordisks Aleksandar Ciric writes that leaders can apply sports principles such as speed of action, clarity, and ...

Speed to market wont guarantee success in todays launch environment. Anticipating what prescribers, patients and payers will ...

For pharma leaders, the critical question is no longer if the AI works, but what behavior it's promoting. Efficiency is table stakes; behavioral governance is the new competitive advantage. Every ...

Canada's medical device regulatory framework has transformed through amendments that fundamentally reshape compliance requirements for MDEL holders. The changes establish new protocols for recall ...

While clinical trial participants provide the essential data that drives medical breakthroughs, the financial systems supporting them remain stuck in the past. Traditional international wire transfers ...

On this week's episode of the Business of Biotech, Dan McHugh, head of the investment team at Yosemite, explains the San Francisco VC group's approach to investing in early-stage cancer therapeutics ...

On this week's episode of the Business of Biotech we speak with Dr. Marc Hedrick, M.D., President and CEO at Plus Therapeutics, about the company's pivot from cell therapy to radiotherapeutics for ...

On this week's episode of the Business of Biotech we're speaking with Alan Bash, President, Carvykti, at Legend Biotech, about how Carvykti became a blockbuster, category-leading CAR T therapy for ...